Positive Bioscience Revenue and Competitors
Estimated Revenue & Valuation
- Positive Bioscience's estimated annual revenue is currently $2.2M per year.
- Positive Bioscience's estimated revenue per employee is $77,500
Employee Data
- Positive Bioscience has 29 Employees.
- Positive Bioscience grew their employee count by 0% last year.
Positive Bioscience's People
| Name | Title | Email/Phone |
|---|
Positive Bioscience Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $12M | 155 | -4% | N/A | N/A |
#2 | $17.3M | 223 | 18% | N/A | N/A |
#3 | $11.1M | 143 | 34% | N/A | N/A |
#4 | $8.2M | 106 | 8% | N/A | N/A |
#5 | $9.5M | 123 | 10% | N/A | N/A |
#6 | $21.2M | 273 | 8% | N/A | N/A |
#7 | $12M | 155 | 8% | N/A | N/A |
#8 | $18.9M | 244 | 5% | N/A | N/A |
#9 | $12.5M | 161 | 9% | N/A | N/A |
#10 | $20.5M | 264 | 8% | N/A | N/A |
What Is Positive Bioscience?
Positive Bioscience is a Biotech startup company. We specialize in creating software to interpret human DNA. Our specialty is providing personalized resources to doctors treating cancer patients. Client data is stored, standardized, quality checked, analyzed, and securely available on the cloud. Both our products, Think Clinic and Think Research are web applications, allowing clients to login and access their data from anywhere at anytime. It's always ready! Think Clinic brings personalized diagnostics to the market! It is designed to asses risk factors and provide personalized treatment resources to doctors treating cancer patients. We show a doctor where cancer has struck and refer to treatments that are best-suited. Think Research is a one-stop solution for comparative genomics, genetic disorders, Pathway analysis, ontologies, and much more. Find us in Facebook: http://www.facebook.com/pages/Positive-Bioscience-Ltd/190726691051581
keywords:N/A
N/A
Total Funding
29
Number of Employees
$2.2M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Positive Bioscience News
Lexaria Bioscience (NASDAQ: LEXX) Announces Positive Results From Hypertension Study. by InvestorBrandNetwork. April 18, 2022 2:15 PM | 3 min read.
Lexaria Bioscience Shares Rise 15% After Positive Data for Study for Hypertension Treatment. Published: April 14, 2022 at 9:35 a.m. ET. comments...
Atom Bioscience Announces Positive Phase 2a Results For Investigational New Drug to Treat Chronic Gout. Published: Mar 21, 2022. Preliminary data suggest...
Other Companies in Mumbai
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.5M | 29 | -29% | N/A |
#2 | $1.5M | 29 | -3% | N/A |
#3 | $2.8M | 29 | N/A | N/A |
#4 | $1.4M | 29 | N/A | N/A |
#5 | N/A | 29 | 61% | N/A |